Multiple epitopes on a human breast-carcinoma-associated antigen

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• Monoclonal antibody (MAb) NCRC-11 identifies an epitope on human breast cancer cells.
• Epitope expression levels correlate with clinical outcomes in operable breast tumors.

Purpose of the Study:

• To isolate and characterize the NCRC-11 target antigen.
• To investigate the nature of NCRC-11 epitopes and their relationship to other breast cancer-associated antigens.

Main Methods:

• Immunoadsorbent chromatography for antigen purification.
• Proteolytic digestion (pronase, papain) and lectin binding (wheat-germ agglutinin) to analyze antigen properties.
• Competitive binding-inhibition assays and sandwich immunoassays to study epitope interactions.

Main Results:

• The NCRC-11 antigen is a large glycoprotein (>400 kd) found in subcellular membranes of breast carcinomas.
• The antigen is sensitive to proteases and contains N-acetylglucosamine.
• NCRC-11 shares epitopes with antibodies like HMFG-1, HMFG-2, and EMA, suggesting topographical association.

Conclusions:

• The NCRC-11 antigen exhibits diverse epitopes related to normal differentiation and malignant transformation in breast cancer.
• These findings contribute to understanding breast cancer heterogeneity and potential diagnostic markers.